Back to search
Autoimmune Bullous Dermatosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Bullous Dermatosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Bullous Dermatosis trials you may qualify forThis Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a i…
Pemphigus and bullous pemphigoid (BP) are severe autoimmune blistering diseases (AIBD) that pose a critical need for new therapeutic approaches. Clinical trials…
The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseas…
This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. Blood samples will be collected from participants with…
Bullous pemphigoid (BP) is the most frequent autoimmune skin disease and mainly affects elderly individuals. BP classically manifests with tense blisters over u…
Cicatricial pemphigoid is an autoimmune blistering disease which affects the skin, mucous membranes, and, in a small subset of patients, the eye. Progressive oc…
This controlled multi-center randomized clinical trial, with direct individual benefit, will compare efficacy and safety of two strategies in non-localized BP c…
The aim of the study is to assess that it will be possible to control with a single cycle of rituximab patient with bullous pemphigoid.